Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension

Authors:

Abstract
No abstract available
Funding Information
  • Biogen

This publication has 26 references indexed in Scilit: